US Stock MarketDetailed Quotes

LXEO Lexeo Therapeutics

Watchlist

6.470
+0.270+4.35%

Close Nov 22 16:00 ET

6.490
+0.020+0.31%

Pre 08:58 ET

213.94MMarket Cap-2470P/E (TTM)

Lexeo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-27.65%-17.81M

-52.76%-20.15M

19.09%-14.87M

-9.05%-59.5M

15.91%-13.98M

-18.32%-13.95M

-13.19M

-18.37M

-23.49%-54.56M

-16.63M

Net income from continuing operations

-46.65%-29.49M

-58.00%-21.24M

-16.21%-21.68M

-12.01%-66.39M

2.68%-14.19M

-17.90%-20.11M

---13.44M

---18.66M

-17.10%-59.28M

---14.58M

Depreciation and amortization

10.65%509K

11.21%496K

6.49%476K

60.96%1.84M

10.11%490K

34.50%460K

--446K

--447K

8,707.69%1.15M

--445K

Other non cash items

----

--530K

--258K

----

Change In working capital

62.14%7.38M

-93.65%-2.26M

814.44%4.01M

-17.25%1.48M

55.36%-1.35M

1.36%4.55M

---1.17M

---561K

-70.35%1.79M

---3.02M

-Change in prepaid assets

-513.64%-270K

557.98%861K

-138.36%-201K

152.46%990K

184.30%698K

-109.89%-44K

---188K

--524K

-247.51%-1.89M

---828K

-Change in payables and accrued expense

57.08%7.99M

-297.59%-2.81M

707.25%4.52M

-52.56%1.91M

13.18%-1.73M

20.31%5.09M

---706K

---745K

-39.67%4.03M

---1.99M

-Change in other current liabilities

31.02%-338K

-14.39%-310K

7.35%-315K

-366.78%-1.42M

-59.80%-318K

-170.72%-490K

---271K

---340K

---304K

---199K

-Change in other working capital

----

50.54%-46K

--0

Cash from discontinued investing activities

Operating cash flow

-27.65%-17.81M

-52.76%-20.15M

19.09%-14.87M

-9.05%-59.5M

15.91%-13.98M

-18.32%-13.95M

---13.19M

---18.37M

-23.49%-54.56M

---16.63M

Investing cash flow

Cash flow from continuing investing activities

-56.60%-83K

-458.97%-218K

-193K

81.69%-165K

31.78%-73K

86.75%-53K

-39K

-379.26%-901K

-107K

Net PPE purchase and sale

-2,666.67%-83K

-446.15%-213K

---185K

82.89%-115K

-192.00%-73K

99.16%-3K

---39K

--0

-257.45%-672K

---25K

Net intangibles purchase and sale

--0

---5K

---8K

78.17%-50K

--0

-13.64%-50K

--0

---229K

---82K

Cash from discontinued investing activities

Investing cash flow

-56.60%-83K

-458.97%-218K

---193K

81.69%-165K

31.78%-73K

86.75%-53K

---39K

--0

-379.26%-901K

---107K

Financing cash flow

Cash flow from continuing financing activities

-101.84%-72K

409.57%291K

90,563.27%88.65M

54,815.87%103.79M

123,644.44%100.07M

11,277.14%3.91M

-94K

-98K

-99.87%189K

-81K

Net issuance payments of debt

-102.85%-111K

28.16%-74K

0.91%-109K

2,293.25%3.58M

2.78%-105K

10,913.89%3.89M

---103K

---110K

---163K

---108K

Net common stock issuance

--0

---54K

--88.75M

--100.25M

--0

----

Net preferred stock issuance

----

--0

----

-99.99%20K

---1K

Proceeds from stock option exercised by employees

30.00%39K

4,555.56%419K

-16.67%10K

-84.64%51K

--0

--30K

--9K

--12K

95.29%332K

--28K

Net other financing activities

----

---86K

---75K

----

Cash from discontinued financing activities

Financing cash flow

-101.84%-72K

409.57%291K

90,563.27%88.65M

54,815.87%103.79M

123,644.44%100.07M

11,277.14%3.91M

---94K

---98K

-99.87%189K

---81K

Net cash flow

Beginning cash position

----

54.76%124.72M

-40.68%80.59M

-60.27%38.7M

----

--80.59M

362.53%135.86M

--97.4M

Current changes in cash

----

498.41%73.59M

179.84%44.13M

611.58%86.02M

----

---18.47M

-151.90%-55.27M

---16.81M

End cash Position

----

219.26%198.31M

54.76%124.72M

----

--62.12M

-40.68%80.59M

--80.59M

Free cash flow

-27.76%-17.89M

-53.96%-20.37M

18.04%-15.06M

-7.57%-59.66M

16.01%-14.05M

-14.87%-14M

---13.23M

---18.37M

-25.00%-55.46M

---16.73M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-27.65%-17.81M	-52.76%-20.15M	19.09%-14.87M	-9.05%-59.5M	15.91%-13.98M	-18.32%-13.95M	-13.19M	-18.37M	-23.49%-54.56M	-16.63M
Net income from continuing operations	-46.65%-29.49M	-58.00%-21.24M	-16.21%-21.68M	-12.01%-66.39M	2.68%-14.19M	-17.90%-20.11M	---13.44M	---18.66M	-17.10%-59.28M	---14.58M
Depreciation and amortization	10.65%509K	11.21%496K	6.49%476K	60.96%1.84M	10.11%490K	34.50%460K	--446K	--447K	8,707.69%1.15M	--445K
Other non cash items	----	----	----	--530K	--258K	----	----	----	----	----
Change In working capital	62.14%7.38M	-93.65%-2.26M	814.44%4.01M	-17.25%1.48M	55.36%-1.35M	1.36%4.55M	---1.17M	---561K	-70.35%1.79M	---3.02M
-Change in prepaid assets	-513.64%-270K	557.98%861K	-138.36%-201K	152.46%990K	184.30%698K	-109.89%-44K	---188K	--524K	-247.51%-1.89M	---828K
-Change in payables and accrued expense	57.08%7.99M	-297.59%-2.81M	707.25%4.52M	-52.56%1.91M	13.18%-1.73M	20.31%5.09M	---706K	---745K	-39.67%4.03M	---1.99M
-Change in other current liabilities	31.02%-338K	-14.39%-310K	7.35%-315K	-366.78%-1.42M	-59.80%-318K	-170.72%-490K	---271K	---340K	---304K	---199K
-Change in other working capital	----	----	----	----	----	----	----	----	50.54%-46K	--0
Cash from discontinued investing activities
Operating cash flow	-27.65%-17.81M	-52.76%-20.15M	19.09%-14.87M	-9.05%-59.5M	15.91%-13.98M	-18.32%-13.95M	---13.19M	---18.37M	-23.49%-54.56M	---16.63M
Investing cash flow
Cash flow from continuing investing activities	-56.60%-83K	-458.97%-218K	-193K	81.69%-165K	31.78%-73K	86.75%-53K	-39K	0	-379.26%-901K	-107K
Net PPE purchase and sale	-2,666.67%-83K	-446.15%-213K	---185K	82.89%-115K	-192.00%-73K	99.16%-3K	---39K	--0	-257.45%-672K	---25K
Net intangibles purchase and sale	--0	---5K	---8K	78.17%-50K	--0	-13.64%-50K	--0	--0	---229K	---82K
Cash from discontinued investing activities
Investing cash flow	-56.60%-83K	-458.97%-218K	---193K	81.69%-165K	31.78%-73K	86.75%-53K	---39K	--0	-379.26%-901K	---107K
Financing cash flow
Cash flow from continuing financing activities	-101.84%-72K	409.57%291K	90,563.27%88.65M	54,815.87%103.79M	123,644.44%100.07M	11,277.14%3.91M	-94K	-98K	-99.87%189K	-81K
Net issuance payments of debt	-102.85%-111K	28.16%-74K	0.91%-109K	2,293.25%3.58M	2.78%-105K	10,913.89%3.89M	---103K	---110K	---163K	---108K
Net common stock issuance	--0	---54K	--88.75M	--100.25M	--100.25M	--0	--0	--0	--0	----
Net preferred stock issuance	----	----	----	--0	----	----	----	----	-99.99%20K	---1K
Proceeds from stock option exercised by employees	30.00%39K	4,555.56%419K	-16.67%10K	-84.64%51K	--0	--30K	--9K	--12K	95.29%332K	--28K
Net other financing activities	----	----	----	---86K	---75K	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-101.84%-72K	409.57%291K	90,563.27%88.65M	54,815.87%103.79M	123,644.44%100.07M	11,277.14%3.91M	---94K	---98K	-99.87%189K	---81K
Net cash flow
Beginning cash position	----	----	54.76%124.72M	-40.68%80.59M	-60.27%38.7M	----	----	--80.59M	362.53%135.86M	--97.4M
Current changes in cash	----	----	498.41%73.59M	179.84%44.13M	611.58%86.02M	----	----	---18.47M	-151.90%-55.27M	---16.81M
End cash Position	----	----	219.26%198.31M	54.76%124.72M	54.76%124.72M	----	----	--62.12M	-40.68%80.59M	--80.59M
Free cash flow	-27.76%-17.89M	-53.96%-20.37M	18.04%-15.06M	-7.57%-59.66M	16.01%-14.05M	-14.87%-14M	---13.23M	---18.37M	-25.00%-55.46M	---16.73M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data